Photo Rounds

Child with yellow nodule

An 18-month-old girl presented to the Dermatology Clinic with a chronic, solitary, well-circumscribed, notably yellow lesion on her forehead. The growth was first noticed by her parents when she was 9 months of age. The lesion subsequently grew for 3 months and stabilized at 12 months. The parents said the lesion didn’t bother the child, who had no notable medical history.

What’s your diagnosis?


 

References

Yellow nodule on child's forehead

The characteristic orange-yellow color is the tip-off to the diagnosis of juvenile xanthogranuloma (JXG). It manifests as asymptomatic solitary or scattered papules or nodules, congenitally, or most commonly during the first year of life.

JXG is an unusual non-Langerhans cell histiocytosis that more commonly affects males. The etiology of JXG is unclear; it is presumed to be due to physical or infectious stimuli that produce a granulomatous histiocytic reaction. JXG typically manifests on the head, neck, upper extremities, and trunk. The appearance of JXG may be similar to that of Langerhans cell histiocytosis. If necessary, the diagnosis of JXG can be confirmed with a skin biopsy, which will reveal Touton-type giant cells and foamy histiocytes.

JXG is a benign and self-limiting disorder and spontaneously regresses within a few years. In rare cases, it can be systemic. If there are multiple lesions, relevant history, or physical exam features suggesting space-occupying lesions, imaging should be performed to rule out lesions in internal organs or structures. Treatment is indicated when there is systemic or symptomatic ocular involvement and may include surgical excision, radiotherapy, and/or systemic chemotherapy. In this case, the patient’s JXG management involved routine monitoring in anticipation of spontaneous resolution.

Image courtesy of John Durkin, MD, FAAD, Department of Dermatology, University of New Mexico School of Medicine, Albuquerque. Text courtesy of Kerry Song, BS, University of New Mexico School of Medicine, and Daniel Stulberg, MD, FAAFP, Department of Family and Community Medicine, University of New Mexico School of Medicine, Albuquerque.

Recommended Reading

A hard-to-reach bleeding lesion
MDedge Family Medicine
Guselkumab maintains psoriasis efficacy long after discontinuation
MDedge Family Medicine
Bathing now more widely accepted as an eczema treatment strategy
MDedge Family Medicine
Are there COVID-19–related ‘long-haul’ skin issues?
MDedge Family Medicine
Are pediatric and adult dermatitis the same disease?
MDedge Family Medicine
Expert shares hyperhidrosis treatment pearls
MDedge Family Medicine
Scaly lesion on forearm
MDedge Family Medicine
Delusional infestation surges during COVID-19 pandemic
MDedge Family Medicine
Survey finds practice gaps in counseling women with hidradenitis suppurativa about pregnancy
MDedge Family Medicine
Molecular insights suggest novel therapies for hidradenitis suppurativa
MDedge Family Medicine